Request that the FDA determine whether the Reference Listed Drug (RLD) LASIX TABLETS, 20 mg, 40 mg and 80 mg; New Drug Application (NDA) 016273 of VALIDUS PHARMACEUTICALS LLC has been voluntarily withdrawn from sale for safety or efficacy reasons | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-4698

Request that the FDA determine whether the Reference Listed Drug (RLD) LASIX TABLETS, 20 mg, 40 mg and 80 mg; New Drug Application (NDA) 016273 of VALIDUS PHARMACEUTICALS LLC has been voluntarily withdrawn from sale for safety or efficacy reasons

Documents

Comments

Description

OPEN

Key Dates

Comment Period OpensApr 29, 2026

Documents

Type	Title	Posted	Comments	Status
Supporting Material	Attachment 1: November 2025 Cumulative Supplement update for LASIX TABLETS	Apr 29, 2026	--

Keywords

CDER

Citizen Petition

Lachman Consultant Services, Inc

determine whether the Reference Listed Drug

(RLD) LASIX TABLETS, 20 mg, 40 mg and 80 mg

New Drug Application (NDA) 016273 of

VALIDUS PHARMACEUTICALS LLC has been voluntarily

withdrawn from sale for

Data from Regulations.gov